IPER - Interdisciplinary approaches and Processes for Reserarch on precision oncology
2024-2026
IPeR aims to create technological devices and algorithms for precision oncology, with the aim to simplify the evaluation and implementation of improvements in colorectal cancer therapy, gastric cancer and metastatic melanoma. IPeR's vision is to build a set of tools for analyzes that lead from the initial diagnosis of a tumor to the identification of the best therapies, both for pharmacological tests and for use in individual therapy. The chain is enabled by the organoids derived from patient as an in vitro replica of the tumor and by enabling technological tools: intelligence algorithms artificial and microfluidic devices.
FRAMEWORK Swich Piedmont Regional Call
PARTNERS
aizOon s.r.l., Fluody s.r.l., Braindtech S.p.A., Consorzio Proplast, Università di Torino, Fondazione per l'Oncologia del Piemonte
We firmly believe that one of the Group’s strengths lies in the transdisciplinary approach that stems from active collaboration between experts from different fields, crucial for achieving results in both research and technological transfer.
